Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Youniss, Fatma M ^a   Sundaresan, Gobalakrishnan ^a   Graham, Laura J ^a   Wang, Li ^a   Berry, Collin R ^a   Dewkar, Gajanan K ^b   Jose, Purnima ^a   Bear, Harry D ^b,c   Zweit, Jamal ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIOCTADECYLTETRAMETHYL INDOTRICARBOCYANINE IODIDE; BRYOSTATIN; FLUORESCENT DYE; GAMMA INTERFERON; INTERLEUKIN 2; IONOMYCIN; UNCLASSIFIED DRUG; 3,3'-DIOCTADECYLINDOCARBOCYANINE; CARBOCYANINE;

ADOPTIVE IMMUNE CELL THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL FUNCTION; CELL HOMING; CELL LABELING; CELL MEMBRANE; CELL PROLIFERATION; CELL THERAPY; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; T LYMPHOCYTE; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME; ADOPTIVE IMMUNOTHERAPY; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CELL SURVIVAL; CELL TRACKING; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; TUMOR CELL LINE;

MURINAE; MUS;

ANIMALS; BREAST NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CELL TRACKING; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-2; IONOMYCIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; SPECTROSCOPY, NEAR-INFRARED; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84908178757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109162     Document Type: Article

References (45)

1. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, et al. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23: 2346-2357.
2. Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, et al. (2002) Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A 99: 16168-16173.
3. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
4. Le HK, Graham L, Miller CH, Kmieciak M, Manjili MH, et al. (2009) Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1+ ionomycin in IL-7+IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2. Cancer Immunol Immunother 58: 1565-1576.
5. Tuttle TM, Bethke KP, Inge TH, Mccrady CW, Pettit GR, et al. (1992) Bryostatin 1-activated T cells can traffic and mediate tumor regression. J Surg Res 52: 543-548.
6. Tuttle TM, Fleming MD, Hogg PS, Inge TH, Bear HD (1994) Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppression. Ann Surg Oncol 1: 53-58.
7. Tuttle TM, Mccrady CW, Inge TH, Salour M, Bear HD (1993) gamma-Interferon plays a key role in T-cell-induced tumor regression. Cancer Res 53: 833-839.
8. Lucignani G, Ottobrini L, Martelli C, Rescigno M, Clerici M (2006) Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol 24: 410-418.
9. Meier R, Golovko D, Tavri S, Henning TD, Knopp C, et al. (2011) Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn Reson Med 65: 756-763.
10. Namavari M, Chang YF, Kusler B, Yaghoubi S, Mitchell BS, et al. (2011) Synthesis of 29-deoxy-29-[18F]fluoro-9-beta-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET. Mol Imaging Biol 13: 812-818.
11. Patel MR, Chang YF, Chen IY, Bachmann MH, Yan X, et al. (2010) Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects. Cancer Res 70: 10141-10149.
12. Akins EJ, Dubey P (2008) Noninvasive imaging of cell-mediated therapy for treatment of cancer. J Nucl Med 49 Suppl 2: 180S-195S.
13. Hong H, Yang Y, Zhang Y, Cai W (2010) Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem 10: 1237-1248.
14. Kircher MF, Gambhir SS, Grimm J (2011) Noninvasive cell-tracking methods. Nat Rev Clin Oncol 8: 677-688.
15. Ottobrini L, Martelli C, Trabattoni DL, Clerici M, Lucignani G (2011) In vivo imaging of immune cell trafficking in cancer. Eur J Nucl Med Mol Imaging 38: 949-968.
16. Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, et al. (2010) Imaging of cellular therapies. Adv Drug Deliv Rev 62: 1080-1093.
17. Wang Q, Ornstein M, Kaufman HL (2009) Imaging the immune response to monitor tumor immunotherapy. Expert Rev Vaccines 8: 1427-1437.
18. Kojima H (2008) [Development of near-infrared fluorescent probes for in-vivo imaging]. Yakugaku Zasshi 128: 1653-1663.
19. Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, et al. (2008) Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med 49: 1162-1170.
20. Dotti G, Tian M, Savoldo B, Najjar A, Cooper LJ, et al. (2009) Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Mol Imaging 8: 230-237.
21. Dubey P, Su H, Adonai N, Du S, Rosato A, et al. (2003) Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 100: 1232-1237.
22. Kim YJ, Dubey P, Ray P, Gambhir SS, Witte ON (2004) Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol 6: 331-340.
23. Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, et al. (2003) Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 21: 405-413.
24. Shu CJ, Radu CG, Shelly SM, Vo DD, Prins R, et al. (2009) Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. Int Immunol 21: 155-165.
25. Su H, Forbes A, Gambhir SS, Braun J (2004) Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol 6: 139-148.
26. Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, et al. (2009) Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 6: 53-58.
27. Seo JH, Jeon YH, Lee YJ, Yoon GS, Won DI, et al. (2010) Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation. J Nucl Med 51: 1637-1643.
28. Penheiter AR, Russell SJ, Carlson SK (2012) The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies. Curr Gene Ther 12: 33-47.
29. Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 23: 983-987.
30. Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, et al. (2010) Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 12: 238-250.
31. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, et al. (2001) Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167: 2379-2387.
32. Wang H, Cao F, De A, Cao Y, Contag C, et al. (2009) Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27: 1548-1558.
33. Parish CR (1999) Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol 77: 499-508.
34. Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, et al. (2000) Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2: 26-40.
35. Heppner GH, Miller FR, Shekhar PM (2000) Nontransgenic models of breast cancer. Breast Cancer Res 2: 331-334.
36. Kalchenko V, Shivtiel S, Malina V, Lapid K, Haramati S, et al. (2006) Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Opt 11: 050507.
37. Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA, et al. (2007) In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res 67: 9180-9189.
38. Lassailly F, Griessinger E, Bonnet D (2010) "Microenvironmental contaminations" induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking. Blood 115: 5347-5354.
39. Du X, Wang X, Ning N, Xia S, Liu J, et al. (2012) Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging. Exp Ther Med 4: 221-225.
40. Cha E, Graham L, Manjili MH, Bear HD (2010) IL-7+IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast Cancer Res Treat 122: 359-369.
41. Yaghoubi SS, Campbell DO, Radu CG, Czernin J (2012) Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics 2: 374-391.
42. Wei LH, Olafsen T, Radu C, Hildebrandt IJ, Mccoy MR, et al. (2008) Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. J Nucl Med 49: 1828-1835.
43. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, et al. (1996) T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 2: 216-223.
44. Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, et al. (2006) In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn Reson Med 56: 498-508.
45. Pittet MJ, Grimm J, Berger CR, Tamura T, Wojtkiewicz G, et al. (2007) In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A 104: 12457-12461.